Nov 14 2022
According to a study epublished by the U.S. National Library of Medicine, “administration of the phytocannabinoid Δ9THC promotes significant recovery from TBI (traumatic brain injury).” Conducted by researchers at the University of South Florida and the James Haley VA Medical Center, the study was published in a recent issue of the peer-reviewed journal Cannabis and …
Nov 13 2022
A new study conducted by researchers at the Penn State College of Medicine has found that while CBD alone is not incredibly effective at treating neuropathic pain, it is effective when mixed with THC, and THC is effective when administered by itself. Published by the journal Biomedicines, the full text of the study can be found …
Nov 11 2022
Medical cannabis treatment was associated with increased white matter coherence in a new peer-reviewed study conducted by researchers at Harvard Medical School and published in the journal Cannabis and Cannabinoid Research. As noted by the study’s abstract, which was published online ahead of print by the National Institute of Health, previous studies have demonstrated abnormal …
Nov 10 2022
A new study provides evidence “supporting efficacy and tolerability of a full-spectrum, high-CBD product for anxiety.” Published in the journal Communications Medicine and conducted by researchers at Harvard Medical School, the study is titled Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial. The study …
Nov 07 2022
According to a study published in the peer-reviewed journal Cannabis and Cannabinoid Research and epublished ahead of print by the National Institute of Health, “medical cannabis may improve their quality of life and comorbidities” in those with Tourette’s syndrome. The study, titled Use of Medical Cannabis in Patients with Gilles de la Tourette’s Syndrome in …
Nov 07 2022
Cannabidiol (CBD) may alleviate liver and skin fibrosis according to a new study published by the peer-reviewed journal Frontiers in Pharmacology. “Cannabidiol (CBD) has been suggested as a potential therapy for inflammatory and fibrotic diseases”, states the study’s abstract. “Cannabidiol was demonstrated to reduce alcohol-induced liver inflammation and steatosis but its specific activity on the …
Nov 03 2022
According to a new study published in the Journal of Clinical Medicine, “cannabis use was associated with a lower risk of hypertension and a lower number of metabolic disorders” among those with the Hepatitis C virus. For the study researchers examined the relationship between current and/or lifetime cannabis use and metabolic disorders in a cohort …
Nov 02 2022
A large majority of patients with Fragile X Syndrome reported that CBD improved some of their symptoms and “made a positive difference overall” in a new study. The study was published in the journal Genes as well as on the website for the U.S. National Library of Medicine, and is titled Parent and Caregiver Perspectives …
Nov 01 2022
According to a new study published in the peer-reviewed Rambam Maimonides Medical Journal, smoking cannabis is more effective than taking CBD extracts if suffering from back pain. This observational open-label study “sought to investigate the effectiveness of cannabis therapy for alleviating low back pain symptoms.” The study was conducted by researchers at Tel Aviv University, …
Oct 27 2022
The state level legalization of recreational marijuana has no discernible impact on how children feel about the potential risks associated with marijuana use. This is according to a new peer-reviewed study being published in the upcoming issue of the journal Cannabis and Cannabinoid Research and epublished ahead of print by the National Institute of Health. …
